|
|
Hello, Test Researcher
|
|
I’m Drew Armstrong, and I oversee our news coverage here at Endpoints. You’re now subscribed to our Early Edition and will receive it in your inbox each morning. You can count on it to give you a fast rundown of the most important news headlines to start the day, every weekday.
|
|
|
Important:If this email lands in your Spam or Promotions folder, move it to your 'Primary' inbox or use the "Report not spam" option in your email platform.
|
|
|
If you ever want to share feedback, you can reach me at
drew@endpointsnews.com. And thank you for welcoming us to your inbox!
|
Drew Armstrong,
Executive Editor
|
|
|
|
you have been subscribed to
|
|
Early Edition
Biopharma
|
|
Early breaking news and major developments
|
|
Business days at 7:15 AM ET
|
|
|
|
|
|
|
|
other reports you might be interested in
|
|
Post-Hoc
Biopharma
|
|
Analysis and insight from the newsroom, plus dispatches from medical meetings and conferences
|
|
One to two times a week
|
|
|
|
|
|
|
|
